Építés alatt – nem éles oldal
Belépés

What researchers published on Petefészekrák

5556 papers, newest first.

Showing 20 of 5556

  • Not labelled yetIdentification and Biological Evaluation of Fisetin as a Novel DYRK1B Inhibitor in Ovarian Cancer with Apoptotic and Ferroptotic Effects.Drug design, development and therapy
  • Not labelled yetProspective Analysis of Breastfeeding History and Ovarian Cancer Risk: Results From the Ovarian Cancer Cohort Consortium.International journal of cancer
  • ÁttekintésExosomal microRNAs in apoptosis and chemoresistance of ovarian cancer: mechanisms and therapeutic implications.Medical oncology (Northwood, London, England)
  • Not labelled yetDevelopment and Validation of Machine Learning Models Incorporating TGFBIp Expression for Prognosis Prediction in Epithelial Ovarian Cancer.Cancer reports (Hoboken, N.J.)
  • Not labelled yetSynergistic antitumor activity of Napabucasin and Curcumin via ROS accumulation and apoptotic cell death induction in ovarian cancer cells.Molecular biology reports
  • Not labelled yetAssociation of Preoperative Systemic Inflammation Response Index and Neutrophil-to-Lymphocyte Ratio with Cytoreduction Outcomes in Ovarian Cancer: A Retrospective Cohort Study.International journal of women's health
  • Not labelled yetRAD52 is a therapeutic vulnerability for acquired PARP inhibitor resistance in ovarian cancer.JCI insight
  • EsetismertetésManagement of a perforated extensive ovarian tumor with radical resection and long-term tumor-free outcome: a case report.Journal of medical case reports
  • Not labelled yetFeasibility of transvaginal ultrasound with endorectal micro-enema for the detection of rectosigmoid anastomotic leakage after cytoreductive surgery for ovarian cancer: preliminary experience from an ambispective single-center study.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • Not labelled yetUHRF1 Supports PARP1 Protein Stability and Ovarian Cancer Progression by Limiting PARP1 Polyubiquitination.Cancer science
  • Not labelled yetCorrigendum to "Methods for isolation, detection and characterization of circulating tumor cells in epithelial ovarian carcinoma and summarized evidence of their association with survival outcome: a scoping review" [Crit. Rev. Oncol./Hematol. 227 (2026) 105614].Critical reviews in oncology/hematology
  • Megfigyeléses vizsgálatPreoperative discrimination of malignant and benign ovarian masses using cfDNA fragmentomics and serum biomarkers.Molecular biomedicine
  • ÁttekintésThe role of carbonic anhydrases IX and XII in hypoxia-driven tumor adaptation and chemoresistance: an underexplored frontier for novel therapeutic strategies in ovarian cancer.Cancer biology & therapy
  • ÁttekintésIdentification of ovarian cancer cell based on mechanical properties of regional heterogeneity of cells.Biosensors & bioelectronics
  • ÁttekintésExploring the molecular pathways of Noncoding RNAs in ovarian cancer: insights into treatment resistance.Journal of ovarian research
  • Not labelled yetFertility and Oncological Outcomes of Ovarian Cancer Patients Treated With Fertility Sparing Surgery.Indian journal of surgical oncology
  • Not labelled yetPAQR5 links microvascular invasion, innate immune inflammatory amplification, and platinum resistance in ovarian cancer.Translational oncology
  • Not labelled yetComment on "Breast cancer prevention in patients with gBRCA-mutated ovarian cancer".Journal of cancer research and clinical oncology
  • EsetismertetésMultidisciplinary management of adult-type ovarian granulosa cell tumor in a patient with severe peripheral arterial disease and chronic limb-threatening ischemia: a case report.Journal of medical case reports
  • Not labelled yetPractical application and exploratory prognostic assessment of the FIGO 2023 stage IA3 criteria in endometrioid endometrial cancer with concurrent ovarian tumours.International journal of clinical oncology